Unveiling the N-Terminal Homodimerization of BCL11B by Hybrid Solvent Replica-Exchange Simulations.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Mar 2021
Historique:
received: 15 03 2021
revised: 29 03 2021
accepted: 30 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 11 5 2021
Statut: epublish

Résumé

Transcription factors play a crucial role in regulating biological processes such as cell growth, differentiation, organ development and cellular signaling. Within this group, proteins equipped with zinc finger motifs (ZFs) represent the largest family of sequence-specific DNA-binding transcription regulators. Numerous studies have proven the fundamental role of BCL11B for a variety of tissues and organs such as central nervous system, T cells, skin, teeth, and mammary glands. In a previous work we identified a novel atypical zinc finger domain (CCHC-ZF) which serves as a dimerization interface of BCL11B. This domain and formation of the dimer were shown to be critically important for efficient regulation of the BCL11B target genes and could therefore represent a promising target for novel drug therapies. Here, we report the structural basis for BCL11B-BCL11B interaction mediated by the N-terminal ZF domain. By combining structure prediction algorithms, enhanced sampling molecular dynamics and fluorescence resonance energy transfer (FRET) approaches, we identified amino acid residues indispensable for the formation of the single ZF domain and directly involved in forming the dimer interface. These findings not only provide deep insight into how BCL11B acquires its active structure but also represent an important step towards rational design or selection of potential inhibitors.

Identifiants

pubmed: 33807484
pii: ijms22073650
doi: 10.3390/ijms22073650
pmc: PMC8036541
pii:
doi:

Substances chimiques

BCL11B protein, human 0
DNA-Binding Proteins 0
Repressor Proteins 0
Transcription Factors 0
Tumor Suppressor Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Norddeutscher Verbund für Hoch- und Höchstleistungsrechnen
ID : MVC00011

Références

Int J Mol Sci. 2010 Oct 19;11(10):4014-34
pubmed: 21152317
PLoS One. 2009;4(4):e5367
pubmed: 19399189
Mol Cell Biol. 2016 Jun 15;36(13):1881-98
pubmed: 27161321
J Chem Theory Comput. 2019 Mar 12;15(3):1863-1874
pubmed: 30768902
PLoS One. 2012;7(5):e37670
pubmed: 22629441
N Engl J Med. 2016 Dec;375(22):2165-2176
pubmed: 27959755
J Am Chem Soc. 2008 Jan 23;130(3):892-900
pubmed: 18163620
Science. 2010 Jul 2;329(5987):85-9
pubmed: 20538915
PLoS One. 2010 Sep 02;5(9):
pubmed: 20824091
Nat Immunol. 2003 Jun;4(6):533-9
pubmed: 12717433
Mol Cell Biol. 2018 Feb 12;38(5):
pubmed: 29203643
J Am Chem Soc. 2005 Apr 6;127(13):4921-9
pubmed: 15796557
J Comput Chem. 2005 Dec;26(16):1668-88
pubmed: 16200636
EMBO J. 2007 Jan 24;26(2):412-23
pubmed: 17245431
J Comput Aided Mol Des. 2017 Jan;31(1):147-161
pubmed: 27787702
J Chem Theory Comput. 2010 Sep 14;6(9):2935-2947
pubmed: 20856692
PLoS One. 2013;8(3):e59369
pubmed: 23527175
Structure. 2000 Nov 15;8(11):1157-66
pubmed: 11080638
Blood. 2006 Oct 15;108(8):2695-702
pubmed: 16809611
J Biol Chem. 2006 Oct 27;281(43):32272-83
pubmed: 16950772
J Inorg Biochem. 2012 Jun;111:146-9
pubmed: 22196020
Annu Rev Biophys. 2019 May 6;48:275-296
pubmed: 30857399
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
J Invest Dermatol. 2009 Jun;129(6):1459-70
pubmed: 19092943
J Biol Chem. 2012 Aug 3;287(32):26971-88
pubmed: 22700985
Int J Cancer. 2021 Feb 26;:
pubmed: 33634864
J Chem Phys. 2020 Jul 28;153(4):044130
pubmed: 32752662
Neuron. 2005 Jan 20;45(2):207-21
pubmed: 15664173
Oncogene. 2007 Aug 9;26(36):5280-9
pubmed: 17325664
Oncogene. 2009 Sep 24;28(38):3380-9
pubmed: 19581932
Oncogene. 2005 Oct 13;24(45):6753-64
pubmed: 16091750
J Phys Chem B. 2019 Jul 18;123(28):5995-6006
pubmed: 31265293
Blood. 2011 Oct 13;118(15):4169-73
pubmed: 21878675
FEBS J. 2015 Dec;282(23):4480-96
pubmed: 26365095
J Biol Chem. 2003 Oct 31;278(44):43041-50
pubmed: 12930829
J Chem Phys. 2009 Oct 28;131(16):165102
pubmed: 19894977
Oncogene. 2007 Aug 30;26(40):5840-50
pubmed: 17369851
J Proteome Res. 2010 Aug 6;9(8):3799-811
pubmed: 20513151
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4278-83
pubmed: 19251658
Nat Genet. 2013 Jun;45(6):592-601
pubmed: 23644491
J Phys Chem B. 2018 Jul 26;122(29):7295-7307
pubmed: 29966412
Oncogene. 2007 May 31;26(26):3797-810
pubmed: 17173069
Cell Stem Cell. 2017 Feb 2;20(2):247-260.e5
pubmed: 28041896
J Comput Aided Mol Des. 2018 Jan;32(1):225-230
pubmed: 29101520
J Chem Inf Model. 2019 Oct 28;59(10):4383-4392
pubmed: 31509400

Auteurs

Lukas Schulig (L)

Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, Germany.

Piotr Grabarczyk (P)

Department of Hematology and Oncology, Internal Medicine C, University Greifswald, 17489 Greifswald, Germany.

Norman Geist (N)

Department of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.

Martin Delin (M)

Department of Hematology and Oncology, Internal Medicine C, University Greifswald, 17489 Greifswald, Germany.

Hannes Forkel (H)

Department of Hematology and Oncology, Internal Medicine C, University Greifswald, 17489 Greifswald, Germany.

Martin Kulke (M)

Department of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.

Mihaela Delcea (M)

Department of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.

Christian A Schmidt (CA)

Department of Hematology and Oncology, Internal Medicine C, University Greifswald, 17489 Greifswald, Germany.

Andreas Link (A)

Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH